This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The principle used in the analysis (intention to treat or treatment completers only) was not clearly stated. The primary health outcomes were survival, knee and limb salvage, and patency rates. Kaplan-Meier methods were used to estimate survival. A list of variables were treated as the independent variables to explain the long-term graft patency in a univariate analysis.
Effectiveness results
The survival rate at three years was 62%, for patients with a functioning graft, 55% for secondary amputees (n=39) and 33% for primary amputees, (p>0.05 for all comparisons, although the primary amputation-patent graft group comparison had a p=0.061). The study revealed that at three years primary patency was 27%, primary assisted patency was 31%, secondary patency was 45%, limb salvage was 54%, and knee salvage was 73%. The univariate analysis demonstrated that the patency rate was dependant on inflow rate (P= 0.0001), availability of venous conduit (P=0.004), number of calf vessels(P= 0.39), the presence of straight flow to the foot (P<0.0001), and the presence of patent pedal vessels (P<0.0001).
Clinical conclusions
The study showed no significant differences between the study groups in terms of primary health outcomes.
Measure of benefits used in the economic analysis
No summary benefit measure was identified in the economic analysis and only separate clinical outcomes were reported.
Direct costs
Some resource use quantities were reported separately from the costs. The cost items were not reported separately from the costs. The costs consisted of those for investigations, radiological procedures, theatre time, anaesthetic time, synthetic grafts, intensive care and in-hospital costs, all based on the NHS service criteria. For the 43patients on whom an amputation was performed, the cost of the physiotherapy and initial rehabilitation, and the cost of the prosthesis were included. It was not explicitly specified from whose point of view the cost analysis was performed. The outpatient follow-up costs were omitted since they were considered to represent a small fraction of the total hospital costs.
